Skip to main content
. 2020 May 16;12(5):1440. doi: 10.3390/nu12051440

Figure 1.

Figure 1

Schematic representation of the to-date-known mechanism of action of natural Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors.